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The P8 proteoglycolipid complex (P8 PGLC) is a glyconjugate expressed by Leishmania mexicana complex
parasites. We previously have shown that vaccination with P8 PGLC provides protection against cutaneous
leishmaniasis in susceptible BALB/c mice. However, the biological importance of this complex remains
unknown. Here we show that P8 PGLC localizes to the surface of Leishmania pifanoi amastigotes and that upon
exposure to macrophages, P8 PGLC binds and induces inflammatory cytokine and chemokine mRNAs such as
tumor necrosis factor alpha and RANTES early after stimulation. Our studies indicate that cytokine and
chemokine induction is dependent upon Toll-like receptor 4 (TLR4). Interestingly, key inflammatory cytokines
and chemokines (such as interleukin-6 [IL-6], macrophage inflammatory protein 1, and beta interferon
[IFN-]) that can be induced through TLR4 activation were not induced or only slightly upregulated by P8
PGLC. Activation by P8 PGLC does not occur in the presence of TLR4 alone and requires both CD14 and
myeloid differentiation protein 2 for signaling; this requirement may be responsible for the limited TLR4
response. This is the first characterization of a TLR4 ligand for Leishmania. In vitro experiments indicate that
L. pifanoi amastigotes induce lower levels of cytokines in macrophages in the absence of TLR4; however,
notably higher IL-10/IFN- ratios were found for TLR4-deficient mice than for BALB/c mice. Further, in-
creased levels of parasites persist in BALB/c mice deficient in TLR4. Taken together, these results suggest that
TLR4 recognition of Leishmania pifanoi amastigotes is important for the control of infection and that this is
mediated, in part, through the P8 PGLC.
Cutaneous leishmaniasis is a dermatropic disease with more
than 1.5 million new cases each year (33). Several species of
Leishmania which are responsible for this disease have been
identified in the New World, including the L. mexicana com-
plex, which is composed of L. mexicana, L. amazonensis, and L.
pifanoi (29). The disease presentations caused by members of
this complex can be characterized as simple or diffuse; the
former is typically a localized ulcerative sore that is often
self-healing, while the latter is disseminated, nonulcerative,
and characterized by a suppression of the cell-mediated im-
mune response (20, 31, 33).
Host-pathogen interactions mediated by microbial compo-
nents have been shown to determine the outcome of microbial
infection. Indeed, parasite-expressed molecules have been
shown to play important roles in mediating Leishmania infec-
tion. Historically, these studies have focused primarily on the
contribution of promastigote-stage glyconjugates, such as li-
pophosphoglycan (LPG), GP63, and GP46, to disease (29, 30,
40–42, 48). However, given the fact that the amastigote form of
the parasite is responsible for the disease pathology, it is im-
portant to understand more fully the contributions of antigenic
components of this stage to the host-parasite interaction and in
disease pathogenesis. Such studies could provide a more com-
prehensive understanding of cutaneous leishmaniasis and po-
tentially be useful in the development of effective vaccines or
immunotherapeutic approaches for control.
The availability of axenic amastigotes of several Leishmania
species allows for detailed studies of the biological and bio-
chemical functions of amastigote-derived antigens. One such
antigen, the P8 proteoglycolipid complex (P8 PGLC), is ex-
pressed by amastigotes. P8 PGLC is composed of a cysteine
and serine metalloproteinase, host-derived ApoE, and four
glycolipids (9). Initial characterization of this complex suggests
that it is biochemically distinct from other well-characterized
amastigote and promastigote glyconjugates (9). Previous stud-
ies have shown that vaccination with P8 PGLC is able to confer
significant protection against L. pifanoi and L. amazonensis in
susceptible BALB/c mice and that protection requires both
CD4 and CD8 T cells (8, 29, 47). Further, in vitro studies have
shown that peripheral blood mononuclear cells of cutaneous
leishmaniasis patients are able to proliferate and produce a Th1-
like response to P8 PGLC, suggesting that this PGLC could be a
potential vaccine candidate (10).
Since P8 PGLC is highly expressed by Leishmania mexicana
complex species, it is plausible that it could play a role in the
interaction of the parasite with its primary host cell, the mac-
rophage. Other leishmania-derived antigenic components,
such as LPG and glycoinositolphospholipids, have been shown
to modulate the macrophage immune response, leading to
persistence or clearance within the host (5, 12, 13, 35). Con-
sequently, P8 PGLC could interact with immune receptors on
or within the macrophage, leading to activation or downregu-
lation of subsequent inflammatory responses.
Toll-like receptors (TLRs) play an important role in the
clearance of microbial pathogens by recognition of pattern-
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associated molecular patterns (PAMPs) and are found on or
within many cells, such as macrophages, dendritic cells, and
epithelial cells. All TLRs share a common adaptor, MyD88,
which is essential for effective downstream signaling and acti-
vation of inflammatory cytokines (25). Numerous studies have
characterized the many bacterial and viral PAMPs that can
signal through TLRs (50). However, studies have only recently
begun to explore the importance of TLRs in parasite clear-
ance. Studies of Trypanosoma, Plasmodium, and Toxoplasma
species have shown that the lack of one or more TLRs can lead
to decreased inflammatory responses and subsequent parasite
persistence (6, 7, 11). TLRs and their associated molecules
have also been shown to be important in the recognition of
Leishmania species as well. Both TLR2 and TLR4 have been
implicated in the recognition of L. major promastigotes; TLR2
has been shown to recognize the promastigote-associated mol-
ecule LPG (4, 14, 27). However, no studies to date have fo-
cused on understanding importance of TLRs in the interaction
with Leishmania amastigotes or their derived molecules.
Here we show that P8 PGLC is expressed on the surface of
L. pifanoi amastigotes and interacts with TLR4 on the macro-
phage surface to induce expression of a distinct subset of in-
flammatory cytokines and chemokines. Further, recognition of
L. pifanoi amastigotes is in part TLR4 dependent, as TLR4/
mice develop exacerbated disease following infection with L.
pifanoi amastigotes. Together these results suggest the impor-
tance of TLR4 in the host-pathogen interaction of this infec-
tious stage with its host.
MATERIALS AND METHODS
Mice. Female C57BL/6 and BALB/c mice were purchased from NCI. C.C3-
TLR4Lps-d/J mice (TLR4/ mice on a BALB/c background) were purchased
from The Jackson Laboratory. TLR4/ and TLR2/ mice (kindly provided by
Richard Flavell and Fayyaz Sutterwala) had been backcrossed to a C57BL/6
background for nine generations. MyD88/ mice were initially obtained from
R. Medizhtov (with the permission of S. Akira); mice were backcrossed for nine
generations to a C57BL/6 background. All animals were housed in the Yale
University School of Medicine Association and Accreditation of Laboratory
Animal Care-approved animal facility. All mice used were between 5 and 12
weeks of age.
Reagents and antibodies. Purified recombinant mouse gamma interferon
(IFN-) and interleukin-10 (IL-10) and biotinylated rat anti-mouse IFN- and
IL-10 were purchased from Pharmingen. Ultrapure lipopolysaccharide (LPS)
(Escherichia coli 0111:B4 strain) and Pam3CSK4 and peptidoglycan (PGN)
(Staphylococcus aureus) were purchased from InvivoGen. Tumor necrosis factor
alpha (TNF-), IL-12p40 (eBioscience), and IFN- (Biosource) enzyme-linked
immunosorbent assays (ELISAs) were employed according to manufacturers’
specifications.
Parasites. L. pifanoi (MHOM/VE/60/Ltrod) and L. amazonensis (MHOM/
BR/77/LTB0016) promastigotes were cultured in Schneider’s Drosophila me-
dium (supplemented with 15% fetal bovine serum) at 22 to 23°C. L. pifanoi
(MHOM/VE/60/Ltrod) amastigotes were cultured at 31°C in F29 medium, as
described previously (47). Parasites were passaged frequently through mice to
maintain infectivity. Soluble leishmania antigen (SLA) was made from L. pifanoi
and L. amazonensis metacyclic promastigotes that underwent repeated freeze-
thaw cycles. For infections, 2  106 L. pifanoi amastigotes were injected subcu-
taneously into the right hind feet of mice. At various time points, the mice were
sacrificed and parasite burdens were determined via limiting-dilution assay (47).
P8 PGLC purification and glycolipid extraction. Membrane preparations of
washed L. pifanoi amastigotes were isolated using nitrogen cavitation and dif-
ferential centrifugation. Membranes were solublized in 1% decanoyl-N-methyl-
glucamide (Mega-10; Sigma-Aldrich), reduced, alkylated, and then fractionated
by Sephadex G25 (GE-HealthCare Biosciences AB) gel exclusion chromatogra-
phy, as previously described (9). The solubilized membranes were then fraction-
ated using anti-P8 immunoaffinity chromatography. The fractions were assessed
for protein by measuring the absorbance at 260 and 280 nm. Protein fractions
were then pooled, concentrated, and stored at 80°C. Samples were then as-
sayed for endotoxin activity via the Limulus amebocyte lysate assay (Cambrex).
All P8 PGLC concentrations (1 to 10 g/ml) used in the experiments tested
below the endotoxin detection levels (0.01 endotoxin unit). Glycolipid extrac-
tion was done as previously described (9).
Cells. 293 HEK cells were obtained from the American Type Culture Collec-
tion (Manassas, VA). Bone marrow-derived macrophages (BMMs) were har-
vested from the femurs and tibiae and generated in vitro by culturing in L-cell
conditioned medium (RPMI 1640 supplemented with 30% L929 cell superna-
tant, 20% heat-inactivated fetal bovine serum [HIFBS], and 1% penicillin/strep-
tomycin) for 4 days. On the fourth day, cells were fed again with L-cell condi-
tioned medium; on day 6, BMMs were harvested, counted, and used for the
experiments described. Elicited peritoneal macrophages were harvested from the
peritoneal cavity at 6 days after injection of 4% thioglycolate broth (Difco
Laboratories). Resident peritoneal macrophages were obtained by flushing the
peritoneal cavity with RPMI 10.
Indirect immunofluorescence microscopy. L. pifanoi amastigotes were applied
in a thin layer at a concentration of 108 cells per ml to spot slides (Cel-line
Associates) and rapidly air dried at room temperature. Slides were blocked for
1 h with phosphate-buffered saline (PBS) plus 1% bovine serum albumin
(Sigma). Slides were subsequently incubated for 1 hour with P8 PGLC mono-
clonal antibody-containing hybridoma supernatant and then washed with
PBS-1% bovine serum albumin. L. pifanoi amastigotes were incubated with
supernatant from a nonsecreting hybridoma cell line as a negative control. The
slides then were incubated for 1 h with rhodamine–anti-mouse immunoglobulin
G (Jackson Immunoresearch) and examined with a Leitz Orthoplan 2 fluores-
cence microscope.
Binding assay of immunopurified P8 PGLC. All binding assays were per-
formed at 4°C. Initially, to visualize the interaction between P8 PGLC and
macrophages, an immunofluorescence binding assay was developed. Peritoneal
macrophages (adhered to coverslips) were incubated with P8 PGLC for 2 h; cells
were subsequently fixed with 1% paraformaldehyde and washed with PBS con-
taining 5% HIFBS. The presence of bound P8 PGLC was detected by incubating
the coverslips at room temperature first with a rabbit polyclonal antibody against
whole P8 PGLC for 45 min. The P8 PGLC was then visualized by subsequently
adding an anti-rabbit rhodamine-labeled antibody. To further assess the nature
of the binding of P8 PGLC to macrophages (saturation and qualitative features),
an ELISA was developed. For this assay, peritoneal macrophages (105/well) were
cultured (37°C) in 96-well microtiter plates overnight. The macrophages were
then placed at 4°C and incubated with various concentrations of P8 PGLC for
1 h. After 1 h, the reaction was developed by using a polyclonal rabbit anti-P8
PGLC antibody followed by an anti-rabbit horseradish peroxidase-conjugated
antibody and then incubating with the TMB substrate (ImmunoPure TMB
[3,3,5,5-tetramethylbenzidine] substrate kit; Pierce). After the reaction was
stopped, the absorbance at 405 nm was measured using an ELISA plate reader.
The specificity of binding of P8 PGLC to macrophages was determined by
examining the binding of the anti-P8 PGLC rabbit antibody in the absence of the
isolated amastigote P8 PGLC.
Cytokine analysis. In vitro analysis of cytokines was performed using draining
lymph node cells prepared at 1 week postinfection in RPMI 10. Cells were plated
at 2.5  106 cells/ml and stimulated with concanavalin A or soluble leishmanial
antigen (50 g or 25 g), cultured with L. pifanoi axenic amastigotes (10:1 or 8:1
ratio), or left untreated. After 72 h, supernatants were harvested. IL-10 and
IFN- ELISAs were performed using antibodies from BD Pharmingen. In vitro
analyses of cytokine responses of peritoneal macrophages or BMMs treated with
either P8 PGLC, PGN, LPS, 	FN-, or L. pifanoi axenic amastigotes were
performed on cultural supernatants after 48 h of stimulation. IFN- (Biosource),
TNF-, and IL-12p40 ELISAs were performed according to the manufacturer’s
recommendations (eBioscience). The IFN- ELISA sensitivity ranged from 15.6
pg/ml to 1,000 pg/ml; TNF- and IL-12p40 ELISA sensitivities ranged from 8
pg/ml to 1,000pg/ml.
RNase protection assay and real-time PCR. Resident peritoneal macrophages
were plated into 24-well plates. The macrophages were stimulated for the indi-
cated times with whole P8 PGLC (10 g protein/well) or extracted P8 PGLC
glycolipids (isolated from a comparable amount of protein). RNA was then
extracted with Trizol (Invitrogen) and used to perform RNase protection assays
with mouse-specific probes (RiboQuant; BD-Bioscience). For real-time PCR
analyses, BMMs were stimulated for various times with P8 PGLC (5 g/ml),
LPS(1 g/ml), or PGN (l0 g/ml) or left unstimulated. RNA was then extracted
with Trizol, and cDNA was synthesized. In other cases, RNA was extracted from
L. pifanoi amastigote-infected wild-type (WT) and TLR4/ (C.C3TLR4Lpsd/j)
mouse feet. QuantiTect Primer assays for inducible nitric oxide synthase, IFN-,
arginase, and GAPDH (glyceraldehyde-3-phosphate dehydrogenase) were used
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in conjunction with QuantiTect Sybr green kits (Qiagen). Real Time PCR was
carried out on a Bio-Rad light cycler. Data were then analyzed using the com-
parative 

 threshold cycle method.
Luciferase assay. Mouse plasmids encoding TLR4, CD14, and myeloid differ-
entiation protein 2 (MD-2) as well as plasmids encoding pIIXB (firefly) and
Renilla luciferase were kind gifts from the laboratories of R. Medzhitov and R.
Baron (Yale University School of Medicine). HEK cells maintained in Dulbec-
co’s medium supplemented with 10% HIFBS were transiently transfected with
various combinations of plasmids using FuGENE 6 (Roche); total DNA was
maintained with pcDNA3 (Invitrogen). The cells were allowed to rest for 24 h
and then stimulated with ultrapure LPS from an E. coli 0111:B4 strain (TLR4
ligand), P8 PGLC, or Pam3CSK4 (TLR2 ligand). After 24 h, the HEK cells were
lysed and were analyzed using the dual luciferase assay reporter system (Pro-
mega) according to the manufacturer’s instructions.
Statistical analysis. Data were analyzed by using Student’s t test to compare
two groups. The t tests were performed with the statistical software GraphPad
Prism 5 (Graph Pad Software, San Diego, CA). P values of 0.05 were consid-
ered significant.
RESULTS
P8 PGLC induces inflammatory cytokine expression in mac-
rophages. We have previously shown that vaccination with P8
PGLC has the ability to provide genetically unrestricted pro-
tection to otherwise susceptible mice (9, 47). Furthermore,
since P8 is highly expressed by L. pifanoi amastigotes, it was
interest to determine the biological function of P8 PGLC.
Indirect immunofluorescence studies were first undertaken to
determine where P8 PGLC localized on L. pifanoi amastigotes.
These analyses as well as earlier studies (reference 16 and
unpublished results) revealed that P8 PGLC localized to the
surface and flagellar pocket of L. pifanoi amastigotes (Fig. 1A).
This finding was consistent with the vaccine antigenic potential
of P8 PGLC (9, 47) and suggested that P8 PGLC might directly
interact with its host cell, the macrophage.
Consequently, we sought to determine whether the P8
PGLC bound to macrophages. Initially, we observed using
indirect immunofluorescence with a polyclonal anti-P8 PGLC
rabbit antibody that the P8 PGLC appeared to bind to the
surface of BALB/c peritoneal macrophages in what appeared
to be a clustered organization (data not shown). To further
investigate the P8 PGLC-macrophage interaction, an ELISA
was developed using BALB/c peritoneal macrophages plated
overnight in 96-well plates and then incubated at 4°C with
immunopurified P8 PGLC. An examination of the kinetics of
the interaction of P8 PGLC with its receptor in the macro-
phage membrane showed a high initial rate and saturation
after 1 hour (Fig. 1B). The binding of P8 PGLC to resident
peritoneal macrophages is dose dependent and appeared to
reach saturation at 5 g/ml of P8 PGLC per 105 macrophages
(Fig. 1C). These results are consistent with a receptor-ligand
interaction between the P8 PGLC and the macrophage.
Given that P8 PGLC bound murine macrophages through a
FIG. 1. P8 PGLC is on the surface of L. pifanoi amastigotes and
binds to murine macrophages in a concentration- and time-dependent
manner. (A) Indirect immunofluorescence of P8 PGLC staining on L.
pifanoi amastigotes (see Materials and Methods). (B and C) Resident
peritoneal macrophages were plated at 105 cells/well and incubated
with 1 g/ml P8 PGLC over a period of time (B) or with increasing
concentrations of P8 PGLC at 4°C for 1 h (C). The level of binding was
determined as indicated in Materials and Methods. Data are repre-
sentative of three independent experiments. OD, optical density.
FIG. 2. P8 PGLC induces the induction of inflammatory cytokine
mRNA. Resident peritoneal macrophages were stimulated for the
indicated times with P8 PGLC (5 g/ml) PGLC and total RNA ex-
tracted. RNA was then used to perform RNase protection assays as
described in Materials and Methods. Data are representative of three
independent experiments with similar results. TGF, transforming
growth factor.
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receptor-ligand-mediated process, we then examined whether
this interaction resulted in specific cytokine responses (inflam-
matory/anti-inflammatory). The expression of a range of cyto-
kine mRNAs in P8 PGLC-stimulated peritoneal macrophages
was examined using an RNase protection assay. These exper-
iments revealed that stimulation with either P8 PGLC alone or
its isolated glycolipids led to the induction of inflammatory
cytokine mRNAs such as those of IL-1 and TNF- as early as
60 min poststimulation (Fig. 2). There was a further upregu-
lation of inflammatory cytokines and chemokines at 4 h post-
stimulation (Fig. 2); additionally, an upregulation of RANTES,
and macrophage inflammatory protein 1 was evident after 4 h
of stimulation. Notably, IFN- mRNA was not upregulated
significantly. This was confirmed via real-time PCR; further,
ELISA (data not shown; sensitivity, 15.6 pg/ml) analyses indi-
cated that IFN- protein was not produced in response to P8
PGLC stimulation.
We then confirmed that P8 PGLC could induce inflamma-
tory cytokine protein as well. Levels of TNF- and IL-12p40
were evaluated, as these are known to have an impact on the
ongoing host immune response to leishmanial infection (18,
49). Macrophages were stimulated with IFN-, P8 PGLC
alone, or P8 PGLC plus IFN- or left untreated (Fig. 3). P8
PGLC alone was able to induce TNF- and IL-12p40 cytokine
production, and this response was further augmented in the
presence of IFN-. These results clearly indicate that P8 PGLC
in the presence or absence of IFN- is able to induce inflam-
matory cytokine responses.
P8 PGLC induces inflammatory cytokines through TLR4.
The ability of P8 PGLC to bind to macrophages in a receptor-
ligand-specific fashion and to induce inflammatory cytokines
early after stimulation suggested a role of innate immune re-
ceptors. Innate receptors such as TLRs have recently been
shown to be important in the establishment of parasite infec-
tion. Recent studies have shown that Leishmania and Trypano-
soma cruzi, a related kinetoplastid parasite, can be recognized
by several TLRs (6, 17, 27, 34). Both TLR2 and TLR4 have
been previously shown to be involved in the recognition of
PAMPs from Leishmania as well as other protozoan parasite
molecules (4, 14, 26, 34). Given the biochemical composition
of the P8 PGLC (9), initial studies were carried out to eluci-
date the importance of TLRs in the recognition of P8 PGLC,
focusing on TLR2 and TLR4.
To evaluate whether TLRs were indeed important for P8
PGLC recognition, we first conducted in vitro studies using WT
and MyD88/ (C57BL/6) peritoneal macrophages exposed to
IFN- alone or a combination of IFN- and P8 PGLC. Although
treatment of WT macrophages with P8 PGLC and IFN- induced
TNF- production, TNF- production was not induced in
MyD88/ macrophages (Fig. 4A). These data indicate a role for
MyD88-dependent signaling in the inflammatory P8 PGLC re-
sponse and suggest that a TLR could be involved in P8 PGLC
recognition.
We then examined whether either TLR2 or TLR4 was im-
FIG. 3. Macrophages stimulated with P8 PGLC produce TNF-
and IL-12p40. Thioglycolate-elicited C57BL/6 macrophages were stim-
ulated with either P8 PGLC (1 g/ml), IFN- (100 ng), or a combi-
nation of both, or left unstimulated, for 48 h. TNF- (A) and IL-12p40
(B) levels in the supernatant were then measured. ELISAs were as-
sayed in duplicate, and data are representative of three independent
experiments with similar results and are expressed as the mean and
standard error.
FIG. 4. P8 PGLC induces the induction of inflammatory cytokines
through TLR. MyD88/ (A), TLR2/ (B), TLR4/ (C) and WT
(A, B, and C) (all C57BL/6 background) thioglycolate elicited-mac-
rophages were stimulated with either P8 PGLC (1 g/ml), LPS (1
g/ml), PGN (5 g/ml) in combination with IFN-, or IFN- alone or
left unstimulated. After 48 h, supernatants were harvested and subse-
quently used to determine TNF- levels. ELISAs were performed in
duplicate, and data are representative of two independent experiments
with similar results and are expressed as the mean and standard error.
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portant in the MyD88-dependent response that we observed.
As shown in Fig. 4B, TLR2/ (C57BL/6) macrophages pro-
duced TNF- at levels similar to those in WT C57BL/6 mice,
suggesting that TLR2 is not important in the recognition of P8
PGLC. In contrast, TLR4/ (C57BL/6) macrophages did not
produce TNF- when stimulated with P8 PGLC compared to
their WT (C57BL/6) counterparts (Fig. 4C). The response of
TLR4/ macrophages was comparable to that of MyD88/
cells (Fig. 4A). Further, the macrophage responses observed
were clearly due to P8 PGLC, as LPS contamination was un-
detectable when examined using the Limulus amebocyte lysate
assay (data not shown). These results suggest that TLR4 is the
receptor that is important in the recognition of P8 PGLC.
P8 PGLC requires both CD14 and MD-2 for signaling
through TLR4. Both CD14 and MD-2 have the ability to as-
sociate with TLR4 on the macrophage and can play an impor-
tant role in the specificity and intensity of TLR4 signaling and
the consequent cytokines and chemokines produced (1, 19, 22,
53). For this reason, studies were undertaken to understand
what role MD-2 and CD14 may play in the interaction of P8
PGLC with TLR4. HEK293 cells were transfected with various
combinations of TLR4, CD14, and/or MD-2 and then stimu-
lated with P8 PGLC. Luciferase assays revealed that cells
transfected with TLR4, CD14, MD2, or TLR4-CD14 or TLR4-
MD2 combinations could not induce NF-B activation follow-
ing P8 PGLC stimulation (Fig. 5 and data not shown). How-
ever, when cells were transfected with TLR4, MD2, and CD14
and stimulated with P8 PGLC, there was a significant increase
(P  0.05) in NF-B activation (Fig. 5). This is unlike the case
for LPS, which has the ability to induce NF-B expression with
TLR4-MD2 alone (46). This suggests that both CD14 and
MD-2 must be present in order for TLR4 to induce signal
transduction. These results further confirmed the importance
of TLR4 in the recognition of P8 PGLC.
TLR4 is important for the recognition of L. pifanoi amasti-
gotes in vitro. To understand whether TLR4 was important for
the recognition of P8 PGLC-expressing Leishmania amasti-
gotes, IFN--primed BMMs were infected with L. pifanoi
amastigotes and the TNF- response examined. WT (BALB/c)
and TLR4/ (C.C3-TLR4Lps-d/J) BMMs were primed with
IFN- for 12 h and then subsequently incubated with various
ratios of L. pifanoi amastigotes for 48 h; culture supernatants
were then assayed for TNF-. In both strains of mice, TNF-
production was observed; however, the TNF- production in
the infected TLR4/ BMMs was significantly lower than that
in their WT counterparts (P  0.05) (Fig. 6). These results
indicate that TLR4/ is important in the recognition of L.
pifanoi amastigotes, consistent with the interaction of P8
PGLC and TLR4 during the parasite’s uptake and entry into
the macrophage.
TLR4 is important for the clearance of L. pifanoi amasti-
gotes in vivo. Since differences were observed in the cytokine
responses of WT and TLR4/ BMMs after infection with L.
pifanoi amastigotes, the actual importance of TLR4 in vivo was
investigated. For these experiments BALB/c mice were em-
ployed, which are known to be highly susceptible to Leishmania.
Both TLR4/ (C.C3-TLR4Lps-d/J) and WT BALB/c mice
were infected with L. pifanoi amastigotes; 1 week later, para-
site levels were determined. The results presented in Fig. 7
show that 1 week after infection, there were significantly higher
numbers of parasites present in the footpad lesions of
TLR4/ mice than in those of their WT counterparts (P 
0.01). These results suggest that TLR4 is important for the
FIG. 5. P8 PGLC requires both CD14 and MD-2 for signaling
through TLR4. HEK293 cells were transiently transfected with com-
binations of TLR4, CD14, and MD-2 as described in Materials and
Methods. The HEK293 cells were subsequently stimulated with P8
PGLC (1 g) for 24 h and then assayed for luciferase activity. Data
presented are the averages from three independently conducted ex-
periments and are expressed as the mean and standard error. , P 
0.05 compared to unstimulated TLR4/MD2-CD14. EV, empty vector
(pcDNA3).
FIG. 6. TLR4 is important for the recognition of L. pifanoi amas-
tigotes in vitro. WT and TLR4/ (C.C3-TLR4Lps-d/J) BMMs were
primed with IFN- (100 ng/ml) for 12 h and then stimulated with L.
pifanoi axenic amastigotes at different parasite/macrophage ratios. Af-
ter 48 h, the supernatants were assessed for TNF- production via
ELISA. The experimental data presented represent the averages from
four independently conducted experiments and are expressed as the
mean and standard error. , P  0.05 compared with WT L. pifanoi-
infected macrophages at the same amastigote/macrophage ratio.
FIG. 7. TLR4 is important for L. pifanoi amastigote clearance in
vivo. WT (BALB/c) and TLR4/ (C.C3-TLR4Lps-d/J) mice were in-
fected with 2  106 L. pifanoi amastigotes in the right hind foot. At 1
week postinfection, parasite burden analysis was carried out. These
data are average from two experiments (n  10) and are expressed as
the mean and standard error. The difference in parasite loads is sta-
tistically significant (**, P  0.01).
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recognition and clearance of L. pifanoi amastigotes and that
lack of TLR4 may cause a defect in the immune response to
the parasite.
In order to determine if there was a defective immune
response in the infected TLR4/ mice, the levels of the
cytokines IFN- and IL-10 were examined, as these cyto-
kines are known to induce or dampen, respectively, macro-
phage and T-cell responses (24, 54) that are critical for
parasite control. At 1 week postinfection, cells from the
draining lymph nodes of WT and TLR4/ infected mice
were stimulated with SLA or L. pifanoi amastigotes at a 10:1
or 8:1 ratio, and then the levels of IFN- and IL-10 were
determined. Interestingly, TLR4/ mice consistently pro-
duced lower levels of both IFN- and IL-10 than WT mice
(Fig. 8). When stimulated with SLA, the overall IL-10/IFN-
ratios ranged from 2.6 to 3.5 in the TLR4/ mice and from
0.44 to 0.32 in the WT mice. When stimulated with L.
pifanoi amastigotes, the overall IL-10/IFN- ratios ranged
from 13.8 to 17.9 in the TLR4/ mice and 9.4 to 11.8 in the
WT mice. Regardless of the stimulus, whether promastigote
or amastigote derived, the TLR4/ mice consistently pro-
duced higher levels of IL-10 than of IFN-. Indeed, given
the role of IL-10 in disease exacerbation of L. mexicana
complex parasites (24, 54), the higher levels of IL-10 in the
TLR4/ mice may indicate a mechanism contributing to
disease exacerbation in the absence of TLR4. These results
suggest that the higher IL-10/IFN- cytokine ratios may be
important in the ineffective control of infection with L.
pifanoi amastigotes in the TLR4/ mice at 1 week postin-
fection.
DISCUSSION
Macrophages are crucial to the innate immune responses to
pathogens. Further, the ability of macrophages to recognize
and respond to Leishmania is critical to the outcome of the
disease. Several antigenic components of Leishmania, such as
phosphoglycans, glycoinositolphospholipids, and LPG, have
been shown to have immunomodulatory effects on the macro-
phage (13, 38, 39). Therefore, it would be in the best interest
of the parasite to manipulate macrophage responses through
stimulation or inhibition of different macrophage functions. In
our studies, macrophage exposure to P8 PGLC led to the
upregulation of a selective subset of inflammatory cytokines
and chemokines, including TNF-, IL-1, RANTES, and mac-
rophage inflammatory protein 1. Interestingly, the amplifying
cytokine IFN- was only slightly induced. Recently, it has been
shown that IFN- induces the upregulation of inducible nitric
oxide synthase, which subsequently leads to Leishmania clear-
ance (15). In accordance with this study, it has been shown that
IFN-/ mice are more susceptible to Leishmania (28).
Hence, minimal IFN- induction could be potentially benefi-
cial to the parasite.
Early induction of inflammatory mRNA as a consequence of
the macrophage exposure indicated the importance of the in-
nate immune response. In an attempt to define the receptor(s)
involved in P8 PGLC induction of cytokines in macrophages,
we focused on TLRs. Our data clearly provide evidence that
TLR4 is important in the recognition of the amastigote-de-
rived P8 PGLC and requires CD14 and MD-2 for NF-B
signaling. Interestingly, mounting evidence has shown that the
requirements for optimal TLR4 signaling are variable and de-
FIG. 8. In vitro cytokine analysis of L. pifanoi-infected WT and TLR4/ mice. Infected draining lymph nodes from WT and TLR4/
mice (n  5, 1 week postinfection) were stimulated with SLA1 (50 g/ml), SLA2 (25 g/ml), L. pifanoi axenic amastigotes (10:1 or 8:1), or
concanavalin A (1 g/ml), or left unstimulated, for 72 h in vitro. The supernatants were then assayed for IFN- (A and B) and IL-10 (C and
D) levels. The results presented are representative of three independent experiments with similar results and are expressed as the mean an
standard error.
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pendent on numerous factors, including the presence of core-
ceptors (37, 51, 52). For example, recent studies demonstrated
that the TLR4/MD-2 complex can distinguish between rough
and smooth forms of LPS. Rough-form LPS signals through
TLR4/MD-2 in the absence of CD14, while smooth-form LPS
requires the presence of CD14 (21, 22). The difference in
requirements of forms of LPS for CD14 leads to the selective
induction of cytokines (21, 22). Furthermore, LPS analogs
have been shown to induce different receptor clusters to the
signaling site, which is thought to be structure specific (52).
The data presented here demonstrate that P8 PGLC, like
smooth LPS, requires the TLR4/MD-2 complex and CD14 to
induce signaling. P8 PGLC is a glycolipid complex consisting of
four glycolipid moieties. However, whether these four glyco-
lipids each interact with TLR4 or whether specific structural
features are critical to the requirement for TLR4/MD2 and
CD14 remains to be determined. Studies have also suggested
that the optimal signaling induced by TLR4 ligands can require
multiple receptors and surface-associated molecules, such as
CD11b/CD18 and HSP90 (37). In addition, given the biochem-
ical complexity of P8 PGLC, it is possible that other macro-
phage receptors may be involved. Consequently, it is tempting
to speculate that P8 PGLC interacts with these associate mol-
ecules or other receptors in coordination, leading to a modu-
lation of the TLR4 inflammatory responses.
Unlike the case for P8 PGLC, interaction with L. pifanoi
amastigotes did not lead to the full abrogation of the TNF-
response in TLR4/ macrophages. This could be due to the
fact that Leishmania spp. are complex parasites and likely have
other surface and/or internal components that could serve as
TLR ligands. The TLR4 response could collaborate with other
TLR or PAMP receptors to induce a full response to Leish-
mania. This hypothesis has been supported by the observation
that TLR2, TLR3, TLR4, and TLR9 can recognize various
Leishmania species and potentially activate in a synergistic
manner to induce potent immune responses (4, 17, 27, 45).
Additional support for this hypothesis comes from studies with
Trypanosoma, Toxoplasma, and Mycobacterium, which have a
requirement for two TLRs to coordinate immune responses
for full pathogen recognition and clearance (2, 3, 11).
In vivo studies have suggested the importance of TLR4 in
the recognition of L. major promastigotes (27). Increased par-
asite burdens in L. major-infected TLR4/ mice were shown
to be associated with an overall increase in Th1- and Th2-like
cytokine production in vitro and increased levels of arginase at
the site of infection (27). In contrast, we observed an overall
decrease in both Th1- and Th2-like cytokines (IFN- and IL-
10) and no difference in the levels of arginase at the site of
infection between L. pifanoi-infected WT and TLR4/ mice
(Fig. 8 and data not shown). Both IFN- and IL-10 are well
documented to play a role in the course of Leishmania infec-
tion (36, 43). IL-10 has been shown to inhibit a multitude of
cytokines such as IL-12 and TNF-, leading to macrophage
deactivation and Leishmania persistence (24, 32). On the other
hand, the Th1 cytokine IFN- is responsible for the activation
of microbicidial mechanisms for Leishmania control (44). In
the L. pifanoi-infected TLR4/ mice, we observed increased
parasite burdens and higher ratios of IL-10 to IFN- compared
to those in WT mice. It is possible that the higher relative
levels of IL-10 to IFN  could lead to macrophage deactivation
and, consequently, higher parasite burdens. Further, it has
been shown in L. mexicana complex infections that IL-10 de-
ficiency leads to decreased parasite numbers at the site of
infection (36). Together these data suggest a role for IL-10 in
the enhanced susceptibility to infection of TLR4/ mice;
however, it is possible that other cytokines mediators may also
be involved (23, 36).
The identification of specific molecules involved in the cross
talk between parasites and host cells could provide novel can-
didate targets for vaccine and chemotherapy development. We
investigated the biological role of P8 PGLC, namely, its ability
to interact with macrophages and its importance in leishmanial
pathogenesis. Our results indicate that P8 PGLC induces in-
flammatory cytokines and chemokines by signaling through
TLR4. We have shown that P8 PGLC recognition by TLR4
depends on the presence of both CD14 and MD-2. Further-
more, the absence of TLR4 leads to decreased TNF- produc-
tion in response to L. pifanoi in vitro. In addition, TLR4/
mice exhibited exacerbated parasite burdens when infected
with L. pifanoi amastigotes. Collectively, our results suggest an
important role for P8 PGLC signaling through TLR4 in leish-
manial pathogenesis. Most notably, this is the first report iden-
tifying an amastigote-derived ligand that can induce macro-
phage inflammatory responses through TLR4.
Future work will focus on detailed studies of the P8 PGLC
structure and the role of TLR in P8 PGLC-induced protection.
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